-+ 0.00%
-+ 0.00%
-+ 0.00%

ANIXA BIOSCIENCES REPORTS ENCOURAGING PATIENT SURVIVAL OBSERVATIONS IN OVARIAN CANCER CAR-T TRIAL; ACHIEVES REGULATORY APPROVAL ENABLING MAJOR DOSE ESCALATION

Reuters·02/09/2026 13:00:05

Please log in to view news